[1]
Kusunoki, M. et al. 2026. The Influence of Age on the Efficacy of a Novel Antidiabetic Drug Imeglimin in Patients With Poorly Controlled Type 2 Diabetes. Journal of Endocrinology & Metabolism. 16, 3 (Jan. 2026), 142–147. DOI:https://doi.org/10.14740/jem1637.